- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed-Refractory Multiple Myeloma in Mexico
Total 80 results
-
Instituto de Seguridad y Servicios Sociales de...UnknownRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma ProgressionMexico
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Grupo Cooperativo de Hemopatías MalignasWithdrawn
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
Grupo Cooperativo de Hemopatías MalignasRecruitingChronic Myeloid Leukaemia Recurrent | Chronic Myeloid Leukemia, in RelapseMexico
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Hospital Universitario Dr. Jose E. GonzalezCompletedLymphoma | Myeloma MultipleMexico
-
Universidad Nacional Autonoma de MexicoInstituto Nacional de Neurología y NeurocirugíaEnrolling by invitationMethylprednisolone | Intranasal Administration | Patients With an Active Multiple Sclerosis RelapseMexico
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
Instituto Mexicano del Seguro SocialCompleted
-
Hospital General de MexicoRecruiting
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
CelgeneCompletedLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Leukemia, Myelomonocytic, ChronicUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
PfizerCompletedNeoplasms | Multiple Myeloma | Lymphoma, Malignant | ThrombocytopeniaUnited States, Argentina, Mexico
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Poland, Taiwan, Korea, Republic of, Japan, United Kingdom, Brazil, Mexico, Turkey, Argentina
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple Myeloma | Amyloidosis | Waldenstrom's Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Janssen-Cilag Ltd.CompletedLymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | LymphoidArgentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
Janssen-Cilag Ltd.CompletedMultiple MyelomaBrazil, Argentina, Mexico, Colombia, Panama
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
AbbVieActive, not recruitingAcute Myeloid Leukemia | Cancer | Multiple Myeloma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States, Australia, Belgium, Canada, Denmark, France, Greece, Hong Kong, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Au...
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapse-Remitting Multiple SclerosisUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Taiwan, Poland, Thailand, Germany, France, Ireland, Greece, Korea, Republic of, United Kingdom, Australia, Italy, India, Argentina, Canada, Spain, Switzerland, Brazil, Mexico
-
AmgenCompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
TakedaCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Belgium, Taiwan, Italy, Israel, China, Turkey, Germany, Greece, Mexico, Colombia, France, Brazil
-
TakedaActive, not recruiting
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
NovartisCompletedBreast Cancer | Multiple Myeloma | Prostate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
Janssen Research & Development, LLCCompletedMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, United Kingdom, France, Japan, Brazil
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia